ketoconazole has been researched along with Fungal Diseases in 305 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia." | 9.07 | Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. ( Grimfors, G; Järnmark, M; Lerner, R; Ljungman, P; Lönnqvist, B; Nyström-Rosander, C; Oberg, G; Palmblad, J, 1993) |
| "The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis." | 9.05 | Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole. ( Cucé, LC; Sampaio, SA; Wroclawski, EL, 1980) |
| "In a comparative study of infection prophylaxis, patients with acute leukemia receiving remission induction therapy were assigned either no prophylaxis, sulfamethoxazole and trimethoprim, ketoconazole, or the combination of sulfamethoxazole and trimethoprim and ketoconazole." | 9.05 | Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. ( Bodey, GP; Estey, E; Fainstein, V; Freireich, EJ; Keating, M; Maksymiuk, A; McCredie, KB; Smith, T, 1984) |
| "The in vitro antifungal activity of itraconazole (ITZ), a new oral triazole antifungal agent, against clinical isolates from patients with systemic mycoses were compared with those of existing systemic antifungals, viz." | 7.68 | [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses]. ( Aoki, K; Matsuzaka, A; Uchida, K; Yamaguchi, H, 1991) |
| "Eight patients with systemic mycoses and with prior treatment failures were treated with itraconazole (600 mg/day) for a mean duration of 5." | 7.68 | High-dose itraconazole in the treatment of severe mycoses. ( Dunn, JF; Fetchick, RJ; Graybill, JR; Hardin, TC; Rinaldi, MG; Sharkey, PK, 1991) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "The efficacy of itraconazole, a new oral triazole, was evaluated at doses of 50-400 mg/day in 64 courses: 39 with coccidioidomycosis, and 25 with other mycoses." | 7.67 | Treatment of mycoses with itraconazole. ( Arathoon, EG; Stevens, DA; Tucker, RM; Williams, PL, 1988) |
| "Oral ketoconazole was given to 50 patients, 36 with superficial and 14 with deep-seated mycoses." | 7.67 | Treatment of superficial and deep-seated mycoses with oral ketoconazole. ( Asconegui, F; Civila, E; Conti-Diaz, IA, 1984) |
| " The clinical signs of corneal infection disappeared after three (Aspergillus infections) to seven weeks (Fusarium infections) of ketoconazole therapy." | 7.67 | Topical ketoconazole for fungal keratitis. ( Cavazos-Adame, H; Martinez, LA; Mohamed, J; Torres, MA, 1985) |
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 7.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 7.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| "Ketoconazole was tested in vitro in three different media against 69 isolates of pathogenic fungi by using a macro-broth dilution procedure." | 6.66 | Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole. ( Dismukes, WE; Shadomy, S; White, SC; Yu, HP, 1985) |
| "Itraconazole is an orally active triazole antifungal drug which has demonstrated a broad spectrum of activity and a favourable pharmacokinetic profile." | 6.38 | Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. ( Clissold, SP; Grant, SM, 1989) |
| " There is a clear need to obtain quick information on itraconazole plasma levels in order to adapt dosage during prophylactic treatment in immunocompromised patients." | 5.28 | Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. ( Boogaerts, MA; De Beule, K; Demuynck, H; Verbist, L; Verhoef, GE; Zachee, P, 1989) |
| "Ketoconazole was used in 11 patients to treat 12 episodes of fungal urinary infections: 6 in the upper urinary tract and 6 presumed to be in the lower urinary tract." | 5.27 | Ketoconazole therapy for fungal urinary tract infections. ( Galgiani, JN; Graybill, JR; Jorgensen, JH; Strandberg, DA, 1983) |
| " In some resistant or extremely severe fungal infections antifungal agents can be used in combinations for their synergistic effects, with subsequent reduction of dosage and potential side-effects." | 5.26 | [First human case of Drechslera longirostrata mycosis. Spondylodiscitis complicating prosthesis endocarditis. Treatment with combined ketoconazole and amphotericin B]. ( Brodaty, D; Chapman, A; Drouhet, E; Guilmet, D; Kouvalchouk, JF; Laudet, J; Ziza, JM, 1982) |
| " In a neutropenic mouse model, itraconazole appeared to be as effective as amphotericin B against Candida albicans, and was more effective than amphotericin B in treating an Aspergillus infection in a patient with chronic granulomatous disease." | 5.07 | Itraconazole in neutropenic patients. ( van't Wout, JW, 1992) |
| "We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia." | 5.07 | Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden. ( Grimfors, G; Järnmark, M; Lerner, R; Ljungman, P; Lönnqvist, B; Nyström-Rosander, C; Oberg, G; Palmblad, J, 1993) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "Itraconazole was administered at doses of 50-400 mg/day to 189 patients with a variety of systemic mycoses for a median of five months." | 5.06 | Adverse events associated with itraconazole in 189 patients on chronic therapy. ( Denning, DW; Haq, Y; Stevens, DA; Tucker, RM, 1990) |
| "In a comparative study of infection prophylaxis, patients with acute leukemia receiving remission induction therapy were assigned either no prophylaxis, sulfamethoxazole and trimethoprim, ketoconazole, or the combination of sulfamethoxazole and trimethoprim and ketoconazole." | 5.05 | Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. ( Bodey, GP; Estey, E; Fainstein, V; Freireich, EJ; Keating, M; Maksymiuk, A; McCredie, KB; Smith, T, 1984) |
| "The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis." | 5.05 | Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole. ( Cucé, LC; Sampaio, SA; Wroclawski, EL, 1980) |
| "Despite the paucity of controlled comparative trials with itraconazole in patients with deep mycoses, results on efficacy are encouraging." | 4.78 | Itraconazole in antifungal therapy. ( Chapman, SW; Cleary, JD; Taylor, JW, 1992) |
| " The dog was treated with ketoconazole and itraconazole perorally for 5 months; however, the osteomyelitis became aggravated, and an amputation from the scapula was performed." | 3.74 | Lecythophora hoffmannii isolated from a case of canine osteomyelitis in Japan. ( Hatai, K; Kamei, K; Murata, Y; Nishimura, K; Sakaeyama, S; Sano, A, 2007) |
| "Amphotericin B is used for the treatment of systemic mycoses and visceral leishmaniasis." | 3.71 | No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes. ( Azas, N; Delmas, F; Di Giorgio, C; Gasquet, M; Timon-David, P, 2001) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "The in vitro antifungal activity of itraconazole (ITZ), a new oral triazole antifungal agent, against clinical isolates from patients with systemic mycoses were compared with those of existing systemic antifungals, viz." | 3.68 | [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses]. ( Aoki, K; Matsuzaka, A; Uchida, K; Yamaguchi, H, 1991) |
| "Eight patients with systemic mycoses and with prior treatment failures were treated with itraconazole (600 mg/day) for a mean duration of 5." | 3.68 | High-dose itraconazole in the treatment of severe mycoses. ( Dunn, JF; Fetchick, RJ; Graybill, JR; Hardin, TC; Rinaldi, MG; Sharkey, PK, 1991) |
| "Twelve patients receiving therapy with an azole agent (ketoconazole, itraconazole, and/or fluconazole) for systemic mycoses experienced drug interactions with rifampin, phenytoin, and/or carbamazepine resulting in substantial decreases in azole concentrations in serum." | 3.68 | Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. ( Denning, DW; Graybill, JR; Hanson, LH; Pappagianis, D; Rinaldi, MG; Sharkey, PK; Stevens, DA; Tucker, RM, 1992) |
| "Combination pairs of 5-fluorocytosine (5-FC) + itraconazole (Itra), 5-FC + fluconazole (Fluc), and amphotericin B (Amph B) + Itra were administered to mice with experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis with a variety of combination ratios." | 3.67 | Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ( Polak, A, 1987) |
| "The efficacy of itraconazole, a new oral triazole, was evaluated at doses of 50-400 mg/day in 64 courses: 39 with coccidioidomycosis, and 25 with other mycoses." | 3.67 | Treatment of mycoses with itraconazole. ( Arathoon, EG; Stevens, DA; Tucker, RM; Williams, PL, 1988) |
| " The clinical signs of corneal infection disappeared after three (Aspergillus infections) to seven weeks (Fusarium infections) of ketoconazole therapy." | 3.67 | Topical ketoconazole for fungal keratitis. ( Cavazos-Adame, H; Martinez, LA; Mohamed, J; Torres, MA, 1985) |
| "Oral ketoconazole was given to 50 patients, 36 with superficial and 14 with deep-seated mycoses." | 3.67 | Treatment of superficial and deep-seated mycoses with oral ketoconazole. ( Asconegui, F; Civila, E; Conti-Diaz, IA, 1984) |
| "A 35-year-old man with osteomyelitis of the calvarium, from which Acremonium kiliense was consistently isolated, was successfully treated with amphotericin-B and ketoconazole in addition to craniectomy." | 3.67 | Acremonium kiliense osteomyelitis of the calvarium. ( Barnes, WG; Brabender, W; Hodges, GR; Ketcherside, J; Rengachary, S, 1985) |
| "I treated seven patients with keratomycosis (four with Candida infections and three with Aspergillus infections) with topical and subconjunctival miconazole." | 3.66 | Miconazole therapy for keratomycosis. ( Foster, CS, 1981) |
| "Ketoconazole is a broad-spectrum antifungal agent which appears promising for treatment of a variety of systemic mycoses." | 3.66 | Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. ( Alexander, GA; Drutz, DJ; Graybill, JR; Jorgensen, JH, 1981) |
| "We treated 29 patients with ketoconazole for systemic mycoses." | 3.66 | Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens. ( Craven, PC; Donovan, W; Graybill, JR; Matthew, EB, 1982) |
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 3.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| "Ketoconazole, an oral, broad-spectrum antifungal agent with relatively low toxicity, is the preferred drug for treatment of chronic mucocutaneous candidiasis and an alternative choice for treatment of thrush, vaginitis, histoplasmosis, and coccidioidomycosis." | 3.66 | Oral antifungal therapy. Current status of ketoconazole. ( Varkey, B, 1983) |
| "Ketoconazole is an effective treatment for chronic superficial candidiasis as well as chronic dermatophytosis." | 3.66 | Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. ( Hay, RJ, 1983) |
| "Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 3.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
| "Two patients, a 48-year-old woman and a 44-year-old man, with fungal keratitis were treated with orally administered ketoconazole, a new antifungal agent." | 3.66 | Oral ketoconazole therapy for keratomycosis. ( Ishibashi, Y, 1983) |
| " The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
| " Bioavailability of ketoconazole was unpredictable." | 2.67 | Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study. ( Browne, M; Cotton, D; Gress, J; Hathorn, J; Marshall, D; McKnight, J; Rubin, M; Skelton, J; Thaler, M; Walsh, TJ, 1991) |
| "Ketoconazole was tested in vitro in three different media against 69 isolates of pathogenic fungi by using a macro-broth dilution procedure." | 2.66 | Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole. ( Dismukes, WE; Shadomy, S; White, SC; Yu, HP, 1985) |
| "Deep fungal infections are an increasing problem in the treatment of acute leukemias and malignant lymphomas." | 2.66 | Prophylaxis of fungal infections with itraconazole during remission-induction therapy. ( Bradford, GR; Prentice, AG, 1989) |
| "Amphotericin B may have been more effective than ketoconazole for the treatment of pneumonia." | 2.66 | Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients. ( Bodey, GP; Elting, L; Fainstein, V; Keating, M; Maksymiuk, A; McCredie, KB, 1987) |
| "Ketoconazole was better tolerated and more effective than nystatin in reducing colonization due to Candida species but was also associated with significantly increased rates of colonization with T." | 2.66 | Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. ( Klosterman, A; Meyers, JD; Shepp, DH; Siegel, MS, 1985) |
| "Ketoconazole was better tolerated than nystatin and neither drug caused toxic effects." | 2.65 | Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients. ( Bergman, AG; Jones, PG; Kauffman, CA; Liepman, MK; McAuliffe, LS, 1984) |
| "Ketoconazole or miconazole was randomly administered to 42 and 46 neutropenic patients respectively." | 2.65 | Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. ( Cruciani, M; Klastersky, J; Meunier-Carpentier, F, 1983) |
| "Fungal infections are often challenging to manage, given the limited numbers of therapeutics and a general lack of applicable clinical literature for their use in a given animal species." | 2.43 | An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals. ( Hector, RF, 2005) |
| "Patients with cancer complicated by neutropenia." | 2.40 | Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. ( Gøtzsche, PC; Johansen, HK, 1997) |
| "Ketoconazole has proven useful in therapy for superficial infections and invasive infections caused by the pathogenic fungi." | 2.38 | Azole antifungal agents. ( Bodey, GP, 1992) |
| "Itraconazole is an orally active triazole antifungal drug which has demonstrated a broad spectrum of activity and a favourable pharmacokinetic profile." | 2.38 | Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. ( Clissold, SP; Grant, SM, 1989) |
| "I have tried to use the AIDS commentaries to keep up with these advances." | 2.38 | Azoles and AIDS. ( Larsen, RA, 1990) |
| "Ketoconazole shampoo has been shown to suppress effectively both the organism's growth and the symptoms and signs of the clinical disorder." | 2.38 | An overview of experience with ketoconazole shampoo. ( Ive, FA, 1991) |
| "Invasive fungal infections are common in immunocompromised patients." | 2.38 | [Systemic mycotic infections]. ( Meunier, F, 1990) |
| " The same results could not be achieved with the same concentration or dosage of either ketoconazole or fluconazole." | 2.38 | Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy. ( Van Cutsem, J, 1990) |
| "Ketoconazole was the first drug sufficiently potent and benign to permit use for both superficial and deep fungal infections." | 2.38 | Fungal infections and their management. ( Graybill, JR; Sharkey, PK, 1990) |
| "Fluconazole appears to be a highly promising agent due its highly favorable pharmacokinetic profile; it is water soluble, is well tolerated, is not metabolized to inactive constituents, it has a long half-life and, unlike the other azoles, high cerebrospinal fluid levels are readily attained for consideration in meningeal mycoses." | 2.38 | New antifungal agents for the systemic mycoses. ( Ringel, SM, 1990) |
| " Liposomal Amphotericin B allowing higher dosage by lower toxicity appears effective as salvage treatment especially in aspergillosis which also responds to Itraconazole available as oral formulation so far." | 2.38 | Antifungal treatment strategy in leukemia patients. ( Büchner, T; Roos, N, 1992) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| " The half-life of ketoconazole is dose-dependent, increases during long term treatment, suggesting auto-inhibition of metabolism." | 2.37 | Clinical pharmacokinetics of ketoconazole. ( Daneshmend, TK; Warnock, DW, 1988) |
| "Superficial fungal infections are frequent and can cause considerable morbidity." | 2.37 | Topical and systemic antifungal agents. ( Bodey, GP, 1988) |
| "Systemic fungal infections are life-threatening diseases that are occurring with increasing frequency, especially in immunocompromised patients." | 2.37 | Recent advances in the treatment of systemic fungal infections. ( Walsh, TJ, 1987) |
| "Miconazole is a parenterally administered agent for patients acutely ill with candidiasis and other mycotic infections." | 2.36 | Antifungal agents used in systemic mycoses. Activity and therapeutic use. ( Craven, PC; Graybill, JR, 1983) |
| "Ketoconazole is an imidazole ring containing antifungal agent used in the treatment of systemic fungal infections." | 1.91 | Formulation and Development of Hyaluronic Acid based Gel with Ketoconazole-Loaded Nanostructured Lipid Carriers in Fungal Infection. ( Gargate, N; Gujar, KN; Kapare, H; Raut, S; Ugale, S, 2023) |
| " However, bioavailability of KZ after oral administration is low from tablets due to its low aqueous solubility." | 1.56 | Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application. ( Ali Youssef, AA; Banala, N; Dudhipala, N, 2020) |
| "Retention hyperkeratosis is a benign and commonly seen skin condition in primary care and dermatology." | 1.36 | Severe retention hyperkeratosis occurring with Susac syndrome. ( Bowen, AR; Harris, K; Pho, LN, 2010) |
| "Terbinafine was the most-active drug against both species, followed by posaconazole against F." | 1.35 | In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. ( Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA, 2008) |
| " Specifically, a microbial natural product library was screened for hits that synergize the effect of a low dosage of ketoconazole (KTC) that alone shows little detectable fungicidal activity." | 1.34 | High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. ( An, R; Bian, J; Chen, X; Chen, Z; Dai, H; Fu, C; Gao, H; Goodfellow, M; Huang, R; Jiang, Y; Kuai, J; Liu, J; Liu, Z; Min, F; Pei, G; Song, Y; Sun, H; Sun, N; Wang, J; Yan, K; Yang, K; You, J; Yu, Z; Zhang, L; Zhang, S; Zhang, X; Zhang, Y; Zhao, W; Zheng, C; Zhou, G; Zhuo, Y, 2007) |
| "Peritonitis is a frequent complication in patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) treatment." | 1.32 | Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD). ( González-Monroy, J; Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ, 2003) |
| " In conclusion, from a pharmacokinetic point of view, all the antifungal agents examined, perhaps with the exception of F, do not offer, when used alone, sufficient guarantees in curing peritonitis." | 1.29 | Pharmacokinetics of antifungal agents. ( Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV, 1993) |
| "Ketoconazole was most often used for presumed or documented oral, urogenital, or esophageal infections and amphotericin B was the preferred agent for disseminated infections and fungemia (p < 0." | 1.29 | Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole. ( Goodwin, SD; Grasela, TH; Pasko, MT; Raebel, MA; Walawander, CA, 1994) |
| "Fluconazole is a triazole antifungal compound with a very original distribution to the meninges and urinary tract; it is mainly used in candidiasis and cryptococcosis." | 1.28 | [Treatment of mycoses and new antifungal agents]. ( Dupont, B, 1989) |
| " There is a clear need to obtain quick information on itraconazole plasma levels in order to adapt dosage during prophylactic treatment in immunocompromised patients." | 1.28 | Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. ( Boogaerts, MA; De Beule, K; Demuynck, H; Verbist, L; Verhoef, GE; Zachee, P, 1989) |
| "Treatment with ketoconazole for 6 weeks resulted in clinical improvement, but proptosis of the left eye slowly appeared after the discontinuation of treatment." | 1.28 | Nasal and retrobulbar mass in a cat caused by Pythium insidiosum. ( Bissonnette, KW; Davis, B; Dykstra, MH; Kaufman, L; Padhye, AA; Robertson, IR; Sharp, NJ, 1991) |
| " The long-term use of trimethoprim-sulfamethoxazole and ketoconazole as a preventive therapy for infections has also been evaluated." | 1.28 | Incidence, severity, and prevention of infections in chronic granulomatous disease. ( Fischer, A; Griscelli, C; Mouy, R; Seger, R; Vilmer, E, 1989) |
| "Treatment with ketoconazole (10 mg kg-1 daily) resulted in improvement in the first cat but unfortunately this animal was subsequently lost to follow-up." | 1.28 | Phaeohyphomycosis caused by Exophiala spinifera in two cats. ( Kettlewell, P; McGinnis, MR; Wilkinson, GT, 1989) |
| "Although blastomycosis is endemic in North America, only 4 cases have been identified in Natal during the last 25 years, and all presented with atypical clinical features." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
| "Three patients with AIDS had an intensely pruritic eosinophilic pustular folliculitis associated with abundant Pityrosporum yeasts in the follicles, demonstrated by direct microscopy." | 1.28 | Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. ( Barranco, JC; Clotet, B; Ferrándiz, C; Lorenzo, JC; Ribera, M, 1992) |
| "Treatment with ketoconazole and potassium iodide did not prevent several relapses." | 1.28 | Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report. ( Costa, AR; Cucé, LC; dos Reis, VM; Lacaz, Cda S; Müller, H; Pegas, JR; Pires, MC; Porto, E; Rodrigues, MC, 1991) |
| "Although blastomycosis is endemic in North America, only four cases have been identified in Natal during the last 25 years and all presented with atypical clinical features." | 1.28 | [Tropical mycoses]. ( Bayles, MA, 1991) |
| " In order to prevent a mycotic infection in these immunocompromised patients, itraconazole, a new broad-spectrum antimycotic drug of the azole group, was given in an oral dosage of 100 mg day-1 (mean duration of prophylactic treatment 24 months)." | 1.28 | Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients. ( König, HJ; Mühldorfer, SM, 1990) |
| " capitatum are usually sensitive to the azole compounds the explanation may be a too low daily dosage for the treatment of severely immunocompromised hosts." | 1.28 | [Trichosporon capitatum septicemia in immunosuppressed patients]. ( Bergerat, JP; Dufour, P; Herbrecht, R; Koenig, H; Liu, KL; Maloisel, F; Oberling, F; Waller, J, 1990) |
| "Diagnosis and treatment of fungal corneal ulcers are discussed briefly." | 1.27 | Keratomycosis caused by Acremonium Recifei, treated with keratoplasty, Miconazole and Ketoconazole. ( Simonsz, HJ, 1983) |
| "Ketoconazole was used in 11 patients to treat 12 episodes of fungal urinary infections: 6 in the upper urinary tract and 6 presumed to be in the lower urinary tract." | 1.27 | Ketoconazole therapy for fungal urinary tract infections. ( Galgiani, JN; Graybill, JR; Jorgensen, JH; Strandberg, DA, 1983) |
| "Ten strains were isolated from untreated genital white piedra lesions and 12 were from the same patients following treatment failure with imidazole compounds." | 1.27 | Antifungal susceptibility testing of Trichosporon beigelii to imidazole compounds. ( Kalter, DC; McBride, ME; Wolf, JE, 1988) |
| "Invasive fungal infections are becoming increasingly frequent among immunocompromised patients and especially among cancer patients." | 1.27 | Treatment of mycoses in cancer patients. ( Meunier-Carpentier, F, 1983) |
| "Multiple phaeohyphomycotic brain abscesses caused by Cladosporium species occurred in a 55 year old woman." | 1.27 | Cerebral phaeohyphomycosis. ( Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B, 1987) |
| "BAY N 7133 was also effective for mouse candidosis by parenteral administration and was effective for guinea pig trichophytosis on topical application." | 1.27 | Antimycotic activity of BAY N 7133 in animal experiments. ( Plempel, M, 1984) |
| "Ketoconazole has been shown to be effective in the treatment of mucocutaneous candidiasis with a reported 97% positive response rate." | 1.27 | Ketoconazole and the antifungals. ( Parkin, JL, 1985) |
| "Ketoconazole was administered orally at daily dosages of 400-800 mg; 5-fluorocytosine was associated in four cases." | 1.27 | Ketoconazole: clinical evaluation in severe fungal infections. ( Arosio, E; Dean, P; Lechi, A; Montesi, G; Pancera, P, 1986) |
| " Ketoconazole given in a dosage of 400 mg daily or more may inhibit testosterone biosynthesis." | 1.27 | [Side effects of ketoconazole]. ( Haneke, E, 1983) |
| " In some resistant or extremely severe fungal infections antifungal agents can be used in combinations for their synergistic effects, with subsequent reduction of dosage and potential side-effects." | 1.26 | [First human case of Drechslera longirostrata mycosis. Spondylodiscitis complicating prosthesis endocarditis. Treatment with combined ketoconazole and amphotericin B]. ( Brodaty, D; Chapman, A; Drouhet, E; Guilmet, D; Kouvalchouk, JF; Laudet, J; Ziza, JM, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 160 (52.46) | 18.7374 |
| 1990's | 96 (31.48) | 18.2507 |
| 2000's | 35 (11.48) | 29.6817 |
| 2010's | 12 (3.93) | 24.3611 |
| 2020's | 2 (0.66) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Yan, K | 1 |
| Zhang, Y | 1 |
| Huang, R | 1 |
| Bian, J | 1 |
| Zheng, C | 1 |
| Sun, H | 1 |
| Chen, Z | 1 |
| Sun, N | 1 |
| An, R | 1 |
| Min, F | 1 |
| Zhao, W | 1 |
| Zhuo, Y | 1 |
| You, J | 1 |
| Song, Y | 1 |
| Yu, Z | 1 |
| Liu, Z | 1 |
| Yang, K | 1 |
| Gao, H | 1 |
| Dai, H | 1 |
| Zhang, X | 1 |
| Wang, J | 1 |
| Fu, C | 1 |
| Pei, G | 1 |
| Liu, J | 1 |
| Zhang, S | 1 |
| Goodfellow, M | 1 |
| Jiang, Y | 1 |
| Kuai, J | 1 |
| Zhou, G | 1 |
| Chen, X | 1 |
| Cuenca-Estrella, M | 1 |
| Gomez-Lopez, A | 1 |
| Gutierrez, MO | 1 |
| Buitrago, MJ | 1 |
| Rodriguez-Tudela, JL | 1 |
| Azor, M | 1 |
| Gené, J | 2 |
| Cano, J | 1 |
| Sutton, DA | 1 |
| Fothergill, AW | 1 |
| Rinaldi, MG | 4 |
| Guarro, J | 3 |
| Garibotto, FM | 1 |
| Garro, AD | 1 |
| Masman, MF | 1 |
| Rodríguez, AM | 1 |
| Luiten, PG | 1 |
| Raimondi, M | 1 |
| Zacchino, SA | 1 |
| Somlai, C | 1 |
| Penke, B | 1 |
| Enriz, RD | 1 |
| Yu, S | 1 |
| Chai, X | 1 |
| Hu, H | 1 |
| Yan, Y | 1 |
| Guan, Z | 1 |
| Zou, Y | 1 |
| Sun, Q | 1 |
| Wu, Q | 1 |
| Gu, W | 1 |
| Wang, S | 1 |
| Liaras, K | 2 |
| Geronikaki, A | 2 |
| Glamočlija, J | 2 |
| Cirić, A | 2 |
| Soković, M | 2 |
| Avupati, VR | 1 |
| Yejella, RP | 1 |
| Akula, A | 1 |
| Guntuku, GS | 1 |
| Doddi, BR | 1 |
| Vutla, VR | 1 |
| Anagani, SR | 1 |
| Adimulam, LS | 1 |
| Vyricharla, AK | 1 |
| Guda, R | 1 |
| Narsimha, S | 1 |
| Babu, R | 1 |
| Muthadi, S | 1 |
| Lingabathula, H | 1 |
| Palabindela, R | 1 |
| Yellu, NR | 1 |
| Kumar, G | 1 |
| Kasula, M | 1 |
| Raut, S | 1 |
| Gargate, N | 1 |
| Ugale, S | 1 |
| Gujar, KN | 1 |
| Kapare, H | 1 |
| Dudhipala, N | 1 |
| Ali Youssef, AA | 1 |
| Banala, N | 1 |
| Wypij, M | 1 |
| Czarnecka, J | 1 |
| Dahm, H | 1 |
| Rai, M | 1 |
| Golinska, P | 1 |
| Lou, D | 1 |
| Cui, X | 1 |
| Bao, SS | 1 |
| Sun, W | 1 |
| Pan, WH | 1 |
| Chen, MC | 1 |
| Dong, YY | 1 |
| Hu, GX | 1 |
| Chen, RJ | 1 |
| Wang, Z | 1 |
| Greenblatt, HK | 1 |
| Greenblatt, DJ | 1 |
| Harris, K | 1 |
| Pho, LN | 1 |
| Bowen, AR | 1 |
| Blanche, S | 1 |
| Dupont, B | 6 |
| Höfling-Lima, AL | 1 |
| De Freitas, D | 1 |
| Godoy, P | 1 |
| Zorat-Yu, ML | 1 |
| Zaror, L | 1 |
| Fischman, O | 2 |
| Shin, S | 1 |
| Kang, CA | 1 |
| Miguélez, S | 1 |
| Obrador, P | 1 |
| Vila, J | 1 |
| Silva, V | 2 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
| Fehér, J | 1 |
| Lengyel, G | 1 |
| Manzano-Gayosso, P | 1 |
| Hernández-Hernández, F | 1 |
| Méndez-Tovar, LJ | 1 |
| González-Monroy, J | 1 |
| López-Martínez, R | 1 |
| el-Agroudy, AE | 1 |
| Sobh, MA | 1 |
| Hamdy, AF | 1 |
| Ghoneim, MA | 1 |
| Ozçelik, B | 1 |
| Citak, S | 1 |
| Cesur, S | 1 |
| Abbasoğlu, U | 1 |
| Içli, F | 1 |
| Dóczi, I | 1 |
| Dósa, E | 1 |
| Varga, J | 1 |
| Antal, Z | 1 |
| Kredics, L | 1 |
| Nagy, E | 1 |
| Udgiri, NR | 1 |
| Mettu, SR | 1 |
| Minenko, SV | 1 |
| Zhukov, NV | 1 |
| Chimishkian, KL | 1 |
| Sokolova, EN | 1 |
| Ptushkin, VV | 1 |
| Anandi, V | 1 |
| Vishwanathan, P | 1 |
| Sasikala, S | 1 |
| Rangarajan, M | 1 |
| Subramaniyan, CS | 1 |
| Chidambaram, N | 1 |
| Braun, JJ | 1 |
| Pauli, G | 1 |
| de Blay, F | 1 |
| Hector, RF | 1 |
| Playford, EG | 1 |
| Webster, AC | 1 |
| Sorrell, TC | 1 |
| Craig, JC | 1 |
| Clyti, E | 1 |
| Sayavong, K | 1 |
| Monchy, D | 1 |
| Chanthavisouk, K | 1 |
| Weinstein, WL | 1 |
| Moore, PA | 1 |
| Sanchez, S | 1 |
| Dietrich, UM | 1 |
| Wooley, RE | 1 |
| Ritchie, BW | 1 |
| Panda, A | 1 |
| Das, H | 1 |
| Deb, M | 1 |
| Khanal, B | 1 |
| Kumar, S | 1 |
| Ho, T | 1 |
| Vrabec, JT | 1 |
| Yoo, D | 1 |
| Coker, NJ | 1 |
| Therese, KL | 1 |
| Bagyalakshmi, R | 1 |
| Madhavan, HN | 1 |
| Deepa, P | 1 |
| Sakaeyama, S | 1 |
| Sano, A | 1 |
| Murata, Y | 1 |
| Kamei, K | 1 |
| Nishimura, K | 1 |
| Hatai, K | 1 |
| Schmid-Wendtner, MH | 1 |
| Korting, HC | 1 |
| Christensen, S | 1 |
| Buhl, M | 1 |
| Tønnesen, EK | 1 |
| Lin, CL | 1 |
| Hu, JT | 1 |
| Yang, SS | 1 |
| Shin, CY | 1 |
| Huang, SH | 1 |
| Wessolossky, M | 1 |
| Haran, JP | 1 |
| Bagchi, K | 1 |
| Knights, CB | 1 |
| Lee, K | 1 |
| Rycroft, AN | 1 |
| Patterson-Kane, JC | 1 |
| Baines, SJ | 1 |
| Looker, DN | 1 |
| Gebhart, RJ | 1 |
| Espinel-Ingroff, A | 2 |
| Shadomy, S | 4 |
| Estey, E | 1 |
| Maksymiuk, A | 2 |
| Smith, T | 1 |
| Fainstein, V | 3 |
| Keating, M | 2 |
| McCredie, KB | 2 |
| Freireich, EJ | 1 |
| Bodey, GP | 5 |
| Gross, M | 1 |
| Sheklakov, ND | 1 |
| Rukavishnikova, VM | 1 |
| Arnold, E | 1 |
| Maksymiuk, AW | 1 |
| Thongprasert, S | 1 |
| Hopfer, R | 1 |
| Luna, M | 1 |
| McGregor, JA | 1 |
| Pont, A | 2 |
| Graybill, JR | 15 |
| Craven, PC | 4 |
| Galgiani, JN | 2 |
| Dismukes, WE | 7 |
| Reitz, RE | 1 |
| Stevens, DA | 6 |
| Polak, A | 2 |
| Weitzman, I | 1 |
| Gordon, MA | 1 |
| Henderson, RW | 1 |
| Lapa, EW | 1 |
| Lefrock, JL | 1 |
| Smith, BR | 1 |
| Manzella, JP | 1 |
| Clark, JK | 1 |
| Farkas, B | 1 |
| Simon, N | 1 |
| Padhye, AA | 3 |
| Kaplan, W | 1 |
| Neuman, MA | 1 |
| Case, P | 1 |
| Radcliffe, GN | 1 |
| Hann, IM | 1 |
| Prentice, HG | 1 |
| Corringham, R | 1 |
| Blacklock, HA | 1 |
| Keaney, M | 1 |
| Shannon, M | 1 |
| Noone, P | 1 |
| Gascoigne, E | 1 |
| Fox, J | 1 |
| Boesen, E | 1 |
| Szawatkowski, M | 1 |
| Hoffbrand, AV | 1 |
| Chapman, JR | 1 |
| Warnock, DW | 4 |
| Pollock, AV | 1 |
| Evans, M | 1 |
| Cucé, LC | 2 |
| Wroclawski, EL | 1 |
| Sampaio, SA | 1 |
| Check, WA | 1 |
| Drutz, DJ | 3 |
| Murphy, AL | 1 |
| Grimmer, H | 1 |
| Foster, CS | 1 |
| Arai, T | 1 |
| Neumann, HA | 1 |
| Berretty, PJ | 1 |
| Jorgensen, JH | 2 |
| Alexander, GA | 1 |
| Pfaff, G | 1 |
| Roberts, DT | 1 |
| Chretien, JH | 1 |
| Garagusi, VF | 1 |
| Török, I | 1 |
| Simon, G | 1 |
| Pap, M | 1 |
| Donovan, W | 1 |
| Matthew, EB | 1 |
| Young, LS | 1 |
| Zazgornik, J | 1 |
| Marosi, L | 1 |
| Kopsa, H | 1 |
| Schmidt, P | 1 |
| Balcke, P | 1 |
| Zyman, H | 1 |
| Thurner, J | 1 |
| Haapasaari, J | 1 |
| Essen, RV | 1 |
| Kahanpää, A | 1 |
| Kostiala, AA | 1 |
| Holmberg, K | 1 |
| Ahlqvist, J | 1 |
| Höffken, G | 1 |
| Lode, H | 1 |
| Dame, WR | 1 |
| Schweppe, KW | 1 |
| Raja Babu, KK | 1 |
| Hoeprich, PD | 2 |
| Stamm, AM | 2 |
| Stiller, RL | 1 |
| Sarosi, GA | 3 |
| Medoff, G | 2 |
| Gregg, CR | 1 |
| Gallis, HA | 1 |
| Fields, BT | 1 |
| Marier, RL | 1 |
| Kerkering, TA | 1 |
| Kaplowitz, LG | 1 |
| Cloud, G | 1 |
| Bowles, C | 1 |
| Varkey, B | 1 |
| Hay, RJ | 2 |
| Drouhet, E | 4 |
| Meunier-Carpentier, F | 3 |
| Van Cutsem, J | 5 |
| Chauvin, JL | 1 |
| Strandberg, DA | 1 |
| Guilmet, D | 1 |
| Kouvalchouk, JF | 1 |
| Chapman, A | 1 |
| Ziza, JM | 1 |
| Laudet, J | 1 |
| Brodaty, D | 1 |
| Ishibashi, Y | 2 |
| Brabender, W | 2 |
| Hodges, GR | 2 |
| Hume, AL | 1 |
| Kerkering, TM | 1 |
| Cruciani, M | 1 |
| Klastersky, J | 1 |
| Horsburgh, CR | 1 |
| Cannady, PB | 1 |
| Kirkpatrick, CH | 1 |
| Brajtburg, J | 1 |
| Kobayashi, GS | 2 |
| Bolard, J | 1 |
| Gumbart, CH | 1 |
| Hervé, F | 1 |
| Barois, A | 1 |
| Beneux, J | 1 |
| Richardson, RC | 1 |
| Jaeger, LA | 1 |
| Wigle, W | 1 |
| Turner, T | 1 |
| Hollmén, A | 1 |
| Lakkakorpi, A | 1 |
| Väätäinen, N | 1 |
| Symoens, J | 1 |
| Cauwenbergh, G | 4 |
| Haneke, E | 1 |
| Simonsz, HJ | 1 |
| Elliott, GS | 1 |
| Whitney, MS | 1 |
| Reed, WM | 1 |
| Tuite, JF | 1 |
| Jones, PG | 2 |
| Kauffman, CA | 3 |
| McAuliffe, LS | 2 |
| Liepman, MK | 2 |
| Bergman, AG | 2 |
| Torres, A | 1 |
| Bermúdez, RH | 1 |
| Garib, J | 1 |
| Ramírez-Ronda, CH | 1 |
| Schiess, RJ | 1 |
| Coscia, MF | 1 |
| McClellan, GA | 1 |
| Conti-Diaz, IA | 1 |
| Civila, E | 1 |
| Asconegui, F | 1 |
| Plempel, M | 1 |
| Rusthoven, JJ | 1 |
| Feld, R | 1 |
| Tuffnell, PG | 1 |
| Kawada, Y | 1 |
| Shimizu, Y | 1 |
| Horie, M | 1 |
| Tokuyama, H | 1 |
| Matsuda, S | 1 |
| Nishiura, T | 1 |
| Moretti, ME | 1 |
| Ito, S | 1 |
| Koren, G | 1 |
| Watt, PR | 1 |
| Robins, GM | 1 |
| Galloway, AM | 1 |
| O'Boyle, DA | 1 |
| Keogh, A | 1 |
| Spratt, P | 1 |
| McCosker, C | 1 |
| Macdonald, P | 1 |
| Mundy, J | 1 |
| Kaan, A | 1 |
| Valantine, HA | 1 |
| Schroeder, JS | 1 |
| Cross, JT | 1 |
| Hickerson, SL | 1 |
| Yamauchi, T | 1 |
| Pai, ST | 1 |
| Platt, MW | 1 |
| Rodrigues, O | 1 |
| Commey, JO | 1 |
| Bickers, DR | 1 |
| Michel, C | 1 |
| Courdavault, L | 1 |
| al Khayat, R | 1 |
| Viron, B | 1 |
| Roux, P | 1 |
| Mignon, F | 1 |
| Crozier, WJ | 1 |
| Wise, KA | 1 |
| Lönnqvist, B | 1 |
| Palmblad, J | 1 |
| Ljungman, P | 1 |
| Grimfors, G | 1 |
| Järnmark, M | 1 |
| Lerner, R | 1 |
| Nyström-Rosander, C | 1 |
| Oberg, G | 1 |
| Grasela, TH | 1 |
| Goodwin, SD | 1 |
| Pasko, MT | 1 |
| Walawander, CA | 1 |
| Raebel, MA | 1 |
| Schutze, GE | 1 |
| Venugopal, PV | 2 |
| Venugopal, TV | 2 |
| Ramakrishna, ES | 1 |
| Ilavarasi, S | 1 |
| Lund, OE | 1 |
| Miño de Kaspar, H | 1 |
| Klauss, V | 1 |
| Odds, FC | 2 |
| Fabris, A | 1 |
| Pellanda, MV | 1 |
| Gardin, C | 1 |
| Contestabile, A | 1 |
| Bolzonella, R | 1 |
| Hilmarsdottir, I | 1 |
| Meynard, JL | 1 |
| Rogeaux, O | 1 |
| Guermonprez, G | 1 |
| Datry, A | 1 |
| Katlama, C | 1 |
| Brücker, G | 1 |
| Coutellier, A | 1 |
| Danis, M | 1 |
| Gentilini, M | 1 |
| Ben Hamida, F | 1 |
| Achard, JM | 1 |
| Westeel, PF | 1 |
| Chandenier, J | 1 |
| Bouzernidj, M | 1 |
| Petit, J | 1 |
| Carme, B | 2 |
| Fournier, A | 1 |
| Johnson, EM | 1 |
| Westenfeld, F | 1 |
| Alston, WK | 1 |
| Winn, WC | 1 |
| Bertini, M | 1 |
| Freilone, R | 1 |
| Vitolo, U | 1 |
| Botto, B | 1 |
| Ciotti, R | 1 |
| Cinieri, S | 1 |
| Di Nota, A | 1 |
| Di Vito, F | 1 |
| Levis, A | 1 |
| Orsucci, L | 1 |
| Pini, M | 1 |
| Rota-Scalabrini, D | 1 |
| Todeschini, G | 1 |
| Resegotti, L | 1 |
| Guiserix, J | 1 |
| Ramdane, M | 1 |
| Finielz, P | 1 |
| Michault, A | 1 |
| Rajaonarivelo, P | 1 |
| Perlman, EM | 1 |
| Binns, L | 1 |
| Mascarenhas, MR | 1 |
| McGowan, KL | 1 |
| Ruchelli, E | 1 |
| Athreya, B | 1 |
| Altschuler, SM | 1 |
| Gøtzsche, PC | 1 |
| Johansen, HK | 1 |
| Carver, PL | 1 |
| Graham-Brown, RA | 1 |
| Su, WF | 1 |
| Lin, JK | 1 |
| Nieh, S | 1 |
| Burgaleta, C | 1 |
| Muñoz, P | 1 |
| Bouza, E | 1 |
| Berenguer Berenguer, J | 1 |
| Muralidhar, S | 1 |
| Sulthana, M | 1 |
| Zhang, H | 1 |
| Lu, Y | 1 |
| Liang, D | 1 |
| Pavese, P | 1 |
| Brion, JP | 1 |
| Lebeau, B | 1 |
| Grillot, R | 1 |
| Ambroise-Thomas, P | 1 |
| García, ME | 1 |
| Caballero, J | 1 |
| Toni, P | 1 |
| Garcia, I | 1 |
| Martinez de Merlo, E | 1 |
| Rollan, E | 1 |
| Gonzalez, M | 1 |
| Blanco, JL | 1 |
| Llop, C | 1 |
| Sala, J | 1 |
| Riba, MD | 1 |
| Kantipong, P | 1 |
| Walsh, DS | 1 |
| Booth, MJ | 1 |
| van der Lugt, JJ | 1 |
| van Heerden, A | 1 |
| Picard, JA | 1 |
| Baroni, A | 1 |
| Perfetto, B | 1 |
| Paoletti, I | 1 |
| De Martino, L | 1 |
| Buommino, E | 1 |
| Ruocco, E | 1 |
| Ruocco, V | 1 |
| Azas, N | 1 |
| Di Giorgio, C | 1 |
| Delmas, F | 1 |
| Gasquet, M | 1 |
| Timon-David, P | 1 |
| Tomimori-Yamashita, J | 1 |
| Ogawa, MM | 1 |
| Hirata, SH | 1 |
| Michalany, NS | 1 |
| Yamashita, HK | 1 |
| Alchorne, M | 1 |
| Tucker, RM | 4 |
| Denning, DW | 3 |
| Hanson, LH | 1 |
| Sharkey, PK | 4 |
| Pappagianis, D | 1 |
| Supparatpinyo, K | 2 |
| Chiewchanvit, S | 2 |
| Hirunsri, P | 2 |
| Uthammachai, C | 2 |
| Nelson, KE | 1 |
| Sirisanthana, T | 2 |
| Cleary, JD | 1 |
| Taylor, JW | 1 |
| Chapman, SW | 1 |
| Williamson, PR | 1 |
| Kwon-Chung, KJ | 1 |
| Gallin, JI | 1 |
| Bayles, MA | 2 |
| van't Wout, JW | 2 |
| Viviani, MA | 4 |
| Laufer, B | 1 |
| Bender, HG | 1 |
| Büchner, T | 1 |
| Roos, N | 1 |
| Baosoung, V | 1 |
| Chaimongkol, B | 1 |
| Kujala, P | 1 |
| Ruutu, P | 1 |
| McGinnis, MR | 2 |
| Campbell, G | 1 |
| Gourley, WK | 1 |
| Lucia, HL | 1 |
| Ferrándiz, C | 1 |
| Ribera, M | 1 |
| Barranco, JC | 1 |
| Clotet, B | 1 |
| Lorenzo, JC | 1 |
| Mesnard, R | 1 |
| Lamy, T | 1 |
| Dauriac, C | 1 |
| Le Prise, PY | 1 |
| Bissonnette, KW | 1 |
| Sharp, NJ | 1 |
| Dykstra, MH | 1 |
| Robertson, IR | 1 |
| Davis, B | 1 |
| Kaufman, L | 1 |
| Dunn, JF | 2 |
| Hardin, TC | 1 |
| Fetchick, RJ | 1 |
| Uchida, K | 2 |
| Matsuzaka, A | 1 |
| Aoki, K | 1 |
| Yamaguchi, H | 3 |
| Hiratani, T | 1 |
| Shibuya, K | 1 |
| Durmaz, B | 1 |
| Thunnissen, PL | 1 |
| Sizoo, W | 1 |
| Hendriks, WD | 1 |
| Novakova, I | 1 |
| Verhagen, CA | 1 |
| Fibbe, WE | 1 |
| de Pauw, BE | 1 |
| van der Meer, JW | 1 |
| Angeli, A | 1 |
| Masera, RG | 1 |
| Gatti, G | 1 |
| Ive, FA | 1 |
| Costa, AR | 1 |
| Porto, E | 1 |
| Pegas, JR | 1 |
| dos Reis, VM | 1 |
| Pires, MC | 1 |
| Lacaz, Cda S | 1 |
| Rodrigues, MC | 1 |
| Müller, H | 1 |
| Caselli, D | 1 |
| Aricò, M | 1 |
| Michelone, G | 1 |
| Cavanna, C | 1 |
| Nespoli, L | 1 |
| Burgio, GR | 1 |
| Walsh, TJ | 3 |
| Rubin, M | 1 |
| Hathorn, J | 1 |
| Gress, J | 1 |
| Thaler, M | 1 |
| Skelton, J | 1 |
| McKnight, J | 1 |
| Browne, M | 1 |
| Marshall, D | 1 |
| Cotton, D | 1 |
| Benhamou, E | 1 |
| Hartmann, O | 1 |
| Noguès, C | 1 |
| Maraninchi, D | 1 |
| Valteau, D | 1 |
| Lemerle, J | 1 |
| Wolf, HH | 1 |
| Scharf, RE | 1 |
| Arning, M | 1 |
| Schneider, W | 1 |
| Ringel, SM | 1 |
| Jacobs, PH | 2 |
| Nall, L | 2 |
| Larsen, RA | 1 |
| Peterie, JD | 1 |
| Greer, DL | 1 |
| Frenkel, L | 1 |
| Counts, GW | 1 |
| Tortorano, AM | 2 |
| Pagano, A | 1 |
| Vigevani, GM | 1 |
| Gubertini, G | 1 |
| Cristina, S | 1 |
| Assaisso, ML | 1 |
| Suter, F | 1 |
| Farina, C | 1 |
| Minetti, B | 1 |
| Otcenásek, M | 1 |
| Piper, JP | 1 |
| Golden, J | 1 |
| Brown, D | 1 |
| Broestler, J | 1 |
| Meunier, F | 2 |
| Haq, Y | 1 |
| Mühldorfer, SM | 1 |
| König, HJ | 2 |
| Malekzadeh, M | 1 |
| Overturf, GD | 1 |
| Auerbach, SB | 1 |
| Wong, L | 1 |
| Hirsch, M | 1 |
| Herbrecht, R | 1 |
| Liu, KL | 1 |
| Koenig, H | 1 |
| Waller, J | 1 |
| Dufour, P | 1 |
| Maloisel, F | 1 |
| Bergerat, JP | 1 |
| Oberling, F | 1 |
| Turhan, A | 1 |
| Connors, JM | 1 |
| Klimo, P | 1 |
| Antoine, GA | 1 |
| Raterink, MH | 1 |
| Grant, SM | 1 |
| Clissold, SP | 1 |
| Spitzer, ED | 1 |
| Boogaerts, MA | 1 |
| Verhoef, GE | 1 |
| Zachee, P | 1 |
| Demuynck, H | 1 |
| Verbist, L | 1 |
| De Beule, K | 2 |
| Prentice, AG | 1 |
| Bradford, GR | 1 |
| Ninane, J | 1 |
| Sluysmans, T | 1 |
| Vermylen, C | 1 |
| Woestenborghs, R | 1 |
| Cornu, G | 1 |
| Mouy, R | 1 |
| Fischer, A | 1 |
| Vilmer, E | 1 |
| Seger, R | 1 |
| Griscelli, C | 1 |
| Kettlewell, P | 1 |
| Wilkinson, GT | 1 |
| Saag, MS | 1 |
| Jay, WM | 1 |
| Bradsher, RW | 1 |
| LeMay, B | 1 |
| Snyderman, N | 1 |
| Angtuaco, EJ | 1 |
| Borghys, AM | 1 |
| Dupré, K | 1 |
| Mariën, K | 1 |
| Degreef, H | 1 |
| Thomas, PA | 2 |
| Abraham, DJ | 2 |
| Kalavathy, CM | 2 |
| Rajasekaran, J | 2 |
| Pizzo, A | 1 |
| Williams, PL | 1 |
| Arathoon, EG | 1 |
| Joseph, PC | 1 |
| Phillips, P | 1 |
| Fetchick, R | 1 |
| Georgiou, A | 1 |
| Kraft, P | 1 |
| Mayer, U | 1 |
| Kendrey, G | 1 |
| Kovács, M | 1 |
| McBride, ME | 1 |
| Kalter, DC | 1 |
| Wolf, JE | 1 |
| Daneshmend, TK | 1 |
| Caya, JG | 1 |
| Farmer, SG | 1 |
| Williams, GA | 1 |
| Franson, TR | 1 |
| Komorowski, RA | 1 |
| Kies, JC | 1 |
| Peto, TE | 1 |
| Bull, R | 1 |
| Millard, PR | 1 |
| Mackenzie, DW | 1 |
| Campbell, CK | 1 |
| Haines, ME | 1 |
| Mitchell, RG | 1 |
| Krivoy, A | 1 |
| Casale, E | 1 |
| Valdivia, RD | 1 |
| Gonzalez, A | 1 |
| Winter, C | 1 |
| Petranyi, G | 1 |
| Meingassner, JG | 1 |
| Mieth, H | 1 |
| Farkas, M | 1 |
| Farkas, I | 1 |
| Adám, J | 1 |
| Ba, J | 1 |
| von Paleske, A | 1 |
| Müllerleile, U | 1 |
| Gressler, V | 1 |
| Garbrecht, M | 1 |
| Hossfeld, DK | 1 |
| Levin, PS | 1 |
| Beebe, WE | 1 |
| Abbott, RL | 1 |
| Gracner, B | 1 |
| Meyer, RD | 1 |
| Elting, L | 1 |
| Murphy, E | 1 |
| Hannon, D | 1 |
| Callaghan, B | 1 |
| Antonelli, M | 1 |
| Vignetti, P | 1 |
| Dahir, M | 1 |
| Mohamed, MS | 1 |
| Favah, AA | 1 |
| Abu Aisha, H | 1 |
| Laajam, M | 1 |
| Yaqoub, B | 1 |
| Chagla, AH | 1 |
| Burges, GE | 1 |
| Walls, CT | 1 |
| Maize, JC | 1 |
| Fitzsimons, R | 1 |
| Peters, AL | 1 |
| Gabal, MA | 1 |
| Tartaglione, TA | 1 |
| Ichise, K | 1 |
| Tanio, T | 1 |
| Saji, I | 1 |
| Okuda, T | 1 |
| Zelen, B | 1 |
| Scrimgeour, E | 1 |
| Anderson, JD | 1 |
| White, SC | 1 |
| Yu, HP | 1 |
| Shepp, DH | 1 |
| Klosterman, A | 1 |
| Siegel, MS | 1 |
| Meyers, JD | 1 |
| Parkin, JL | 1 |
| Moriello, KA | 1 |
| Lechi, A | 1 |
| Montesi, G | 1 |
| Dean, P | 1 |
| Pancera, P | 1 |
| Arosio, E | 1 |
| Seeliger, HP | 1 |
| Johnson, RJ | 1 |
| Ramsey, PG | 1 |
| Gallagher, N | 1 |
| Ahmad, S | 1 |
| Torres, MA | 1 |
| Mohamed, J | 1 |
| Cavazos-Adame, H | 1 |
| Martinez, LA | 1 |
| Krcová, V | 1 |
| Krc, I | 1 |
| Kubis, M | 1 |
| Mlcochová, E | 1 |
| Podivínská, I | 1 |
| Vartian, CV | 1 |
| Shlaes, DM | 1 |
| Ajello, L | 1 |
| Ketcherside, J | 1 |
| Rengachary, S | 1 |
| Barnes, WG | 1 |
| Cohen, AN | 1 |
| Offerhaus, L | 1 |
| Mazzoni, A | 1 |
| Fiorentini, C | 1 |
| Cevenini, R | 1 |
| Nanetti, A | 1 |
| Greene, CE | 1 |
| Miller, DM | 1 |
| Blue, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.[NCT04824261] | 100 participants (Anticipated) | Interventional | 2021-06-01 | Not yet recruiting | |||
| Feedback Control of FSH Secretion in the Human Male[NCT00392457] | 175 participants (Anticipated) | Interventional | 1995-07-31 | Completed | |||
| Mechanisms of Hormonal Control of Spermatogenesis in Man[NCT02147964] | Phase 2 | 0 participants (Actual) | Interventional | 2019-06-30 | Withdrawn (stopped due to No funding was obtained for this study.) | ||
| Mechanisms of Control of the Intratesticular Hormonal Milieu in Man[NCT01215292] | Phase 1/Phase 2 | 46 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01215292)
Timeframe: 10 days
| Intervention | ng/mL (Median) |
|---|---|
| Acyline + Testosterone Gel (Tgel)+ Placebo | .87 |
| Acyline + Tgel + Ketoconazole 400mg | 0.5 |
| Acyline + Tgel + Ketoconazole 800mg | 0.12 |
| Acyline & TGel & Dutasteride 2.5mg | 1.7 |
| Acyline & TGel & Anastrazole 1mg | 3.6 |
(NCT01215292)
Timeframe: 10 days
| Intervention | ng/mL (Median) |
|---|---|
| Acyline + Testosterone Gel (Tgel)+ Placebo | 3.17 |
| Acyline & TGel & Ketoconazole 400 mg | 2.08 |
| Acyline & TGel & Ketoconazole 800 mg | 1.46 |
| Acyline & TGel & Dutasteride | 0.12 |
| Acyline & TGel & Anastrazole | 3.63 |
(NCT01215292)
Timeframe: 10 days
| Intervention | ng/mL (Median) |
|---|---|
| Acyline + Testosterone Gel + Placebo | 14 |
| Acyline + Tgel + Ketoconazole 400mg | 3.7 |
| Acyline + Tgel + Ketoconazole 800mg | 1.7 |
| Acyline & TGel & Dutasteride 2.5mg | 18.4 |
| Acyline & TGel & Anastrazole 1mg | 24.0 |
65 reviews available for ketoconazole and Fungal Diseases
| Article | Year |
|---|---|
Liver injury associated with ketoconazole: review of the published evidence.
Topics: Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A Inhibitor | 2014 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 2003 |
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itracon | 2005 |
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
Topics: Adult; Antifungal Agents; Critical Illness; Fluconazole; Humans; Immunocompromised Host; Incidence; | 2006 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; | 2007 |
[Prophylactic antifungal treatment in critically ill patients. A survey of a Cochrane review].
Topics: Adult; Antifungal Agents; Critical Illness; Evidence-Based Medicine; Fluconazole; Humans; Immunocomp | 2008 |
Paecilomyces lilacinus olecranon bursitis in an immunocompromised host: case report and review.
Topics: Aged, 80 and over; Animals; Bursitis; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised H | 2008 |
[Imidazole preparations in mycology].
Topics: Animals; Antifungal Agents; Candidiasis; Clotrimazole; Coccidioidomycosis; Cryptococcosis; Dermatomy | 1984 |
[Action mechanism and resistance of drugs used in visceral mycoses].
Topics: Animals; Antifungal Agents; Candida albicans; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resi | 1980 |
The current status of systemic antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Mico | 1982 |
Current management of fungal enteritis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Diarrhea; Enteritis; Histoplasmosis; Humans; Imidazo | 1982 |
[Systemic antimycotic treatment].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; K | 1982 |
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketocona | 1983 |
Ketoconazole.
Topics: Antifungal Agents; Bacteria; Costs and Cost Analysis; Drug Interactions; Humans; Imidazoles; Ketocon | 1983 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
Antifungal agents useful in therapy of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosi | 1983 |
Ketoconazole, a new step in the management of fungal disease.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Dermatomycoses; Humans; Ketoconazole; Kin | 1983 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clini | 1984 |
Antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Itraconazole; Ketoc | 1995 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Flu | 1994 |
Is there a correlation between serum antifungal drug concentration and clinical outcome?
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Humans; Injections, Intravenous; Itraconazo | 1994 |
Fungal peritonitis in patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administ | 1994 |
Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
Topics: Administration, Oral; Animals; Antifungal Agents; Guinea Pigs; Humans; Itraconazole; Ketoconazole; M | 1993 |
Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Ketoconazole; Male; Mycoses; Penicillium | 1993 |
Complicated soft tissue infection with prepatellar bursitis caused by Paecilomyces lilacinus in an immunocompetent host: case report and review.
Topics: Adult; Antifungal Agents; Bursitis; Combined Modality Therapy; Humans; Immunocompetence; Ketoconazol | 1996 |
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Myco | 1997 |
Use of azoles for systemic antifungal therapy.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; I | 1997 |
Dandruff and seborrhoeic dermatitis: causes and management.
Topics: Antifungal Agents; Dermatitis, Seborrheic; Humans; Ketoconazole; Malassezia; Mycoses; Scalp Dermatos | 1997 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia | 1995 |
[Prevention and treatment of fungal infections in solid-organ transplant recipients].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Heart Transplantation; Hum | 1995 |
[Antifungal agent resistance of yeasts of clinical significance].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Dru | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top | 1995 |
Azole antifungal agents.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Myc | 1992 |
Itraconazole in antifungal therapy.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Ketoconazole; Meta-Analysis as Topic; Mycoses | 1992 |
Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Follow-Up Studies; Granulomatou | 1992 |
[Current developments in antimycotic therapy in gynecology and obstetrics].
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Flu | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itra | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; | 1991 |
Lung abscess due to Pseudallescheria boydii in the course of acute leukaemia. Report of a case and review of the literature.
Topics: Adolescent; Female; Humans; Ketoconazole; Leukemia, Myelomonocytic, Acute; Lung Abscess; Mycoses; Ps | 1992 |
[Importance of the new triazoles in antifungal therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Dru | 1991 |
[Mycoses and adrenocortical function. New pathogenetic aspects of adrenal hypofunction].
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adrenal Glands; Adrenal Insufficiency; | 1991 |
An overview of experience with ketoconazole shampoo.
Topics: Clinical Trials as Topic; Dermatitis, Seborrheic; Glucocorticoids; Humans; Ketoconazole; Malassezia; | 1991 |
Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Itraconazole; Ketoconazole; Mycoses | 1990 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphtha | 1990 |
New antifungal agents for the systemic mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Structure; Mycoses | 1990 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ke | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; | 1990 |
Amphotericin B. Still the 'gold standard' for antifungal therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Humans; Ketoconazole; Mycoses; Risk Factors | 1990 |
Bipolaris: a serious new fungal pathogen of the paranasal sinus.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Immunosuppression Thera | 1989 |
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
Topics: Animals; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
Testing of organisms for susceptibility to triazoles: is it justified?
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazol | 1989 |
New antifungal agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi | 1989 |
Itraconazole and fluconazole: new drugs for deep fungal infection.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
Azole antifungal agents: emphasis on new triazoles.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoco | 1988 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; D | 1987 |
Azole antifungal drugs: old and new.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensi | 1988 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; | 1988 |
Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents.
Topics: Amphotericin B; Antifungal Agents; Humans; Ketoconazole; Mycoses; Triazoles | 1988 |
The action and safety of ketoconazole: a brief literature review.
Topics: Chemical Phenomena; Chemistry; Humans; Ketoconazole; Mycoses | 1988 |
Clinical pharmacokinetics of ketoconazole.
Topics: Administration, Intravaginal; Administration, Topical; Drug Interactions; Humans; Ketoconazole; Leuk | 1988 |
Topical and systemic antifungal agents.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ket | 1988 |
Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Humans; Ketoconazole; Male; Middle Aged; Mycoses | 1988 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
Topics: Amphotericin B; Drug Administration Schedule; Humans; Immunosuppression Therapy; Ketoconazole; Micon | 1986 |
30 trials available for ketoconazole and Fungal Diseases
| Article | Year |
|---|---|
A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: ten-year follow-up.
Topics: Adult; Antifungal Agents; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft | 2004 |
Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Drug Combinations; Drug Therapy, Combi | 1984 |
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
Topics: Amphotericin B; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Imidazoles; Immunosuppr | 1982 |
Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Chromoblastomycosis; Clinical Trials as Top | 1980 |
Oral antifungal agent effective even for widespread infections.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
Ketoconazole: a major innovation for treatment of fungal disease.
Topics: Animals; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topi | 1980 |
Treatment of pityrosporum folliculitis with ketoconazole (R 41400).
Topics: Adult; Clinical Trials as Topic; Female; Folliculitis; Humans; Imidazoles; Ketoconazole; Malassezia; | 1981 |
An evaluation of two years of clinical experience with ketoconazole.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Female; Humans; I | 1982 |
Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients.
Topics: Agranulocytosis; Antifungal Agents; Candidiasis; Drug Combinations; Female; Humans; Imidazoles; Keto | 1983 |
Efficacy of ketoconazole v nystatin in prevention of fungal infections in neutropenic patients.
Topics: Adult; Agranulocytosis; Female; Humans; Ketoconazole; Male; Middle Aged; Mycoses; Neutropenia; Nysta | 1984 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clini | 1984 |
Effect of prophylactic ketoconazole and nystatin on fungal flora.
Topics: Adolescent; Adult; Clinical Trials as Topic; Humans; Ketoconazole; Leukemia; Lymphoma; Mycoses; Nyst | 1984 |
Ketoconazole to reduce the need for cyclosporine after cardiac transplantation.
Topics: Actuarial Analysis; Adult; Cost Savings; Cyclosporine; Drug Interactions; Drug Therapy, Combination; | 1995 |
Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Bacteremia; Bacterial Infections; Double-B | 1993 |
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chem | 1996 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
Itraconazole in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Humans; Itraconazole; Ketoconazole; M | 1992 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
Topics: Adolescent; Agranulocytosis; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmo | 1991 |
Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Feces; Female; Humans; Infan | 1990 |
Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Topics: Adult; Agranulocytosis; Amphotericin B; Fever; Humans; Immune Tolerance; Ketoconazole; Mycoses; Neop | 1991 |
Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial.
Topics: Amphotericin B; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Dr | 1991 |
Adverse events associated with itraconazole in 189 patients on chronic therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Micona | 1990 |
Ketoconazole versus nystatin as prophylaxis against fungal infection for lymphoma patients receiving chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophos | 1987 |
Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Ketoc | 1989 |
Itraconazole versus ketoconazole for the prophylaxis of fungal infection in neutropenic children: results of two consecutive nonrandomized studies.
Topics: Adolescent; Agranulocytosis; Antifungal Agents; Child; Child, Preschool; Clinical Trials as Topic; F | 1989 |
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Female; Humans; Ketoconazole; Male; Middle Aged; Mycoses; N | 1987 |
Ketoconazole prophylaxis in patients with solid tumours receiving aggressive immunosuppressive therapy. An open randomized comparison between 200 mg/d and 400 mg/d doses.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Immunosuppressive Agents; Ketoconaz | 1985 |
Treatment of systemic mycoses with ketoconazole: in vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole.
Topics: Blastomyces; Clinical Trials as Topic; Coccidioides; Cryptococcus neoformans; Culture Media; Histopl | 1985 |
Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
Topics: Agranulocytosis; Candida albicans; Candidiasis; Clinical Trials as Topic; Environment, Controlled; H | 1985 |
211 other studies available for ketoconazole and Fungal Diseases
| Article | Year |
|---|---|
High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.
Topics: Algorithms; Animals; Antifungal Agents; Cell Line; Depsipeptides; Disease Models, Animal; Drug Combi | 2007 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; H | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; | 2008 |
New small-size peptides possessing antifungal activity.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryp | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Stero | 2010 |
Synthesis and antimicrobial activities of novel 1H-dibenzo[a,c]carbazoles from dehydroabietic acid.
Topics: Abietanes; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infe | 2010 |
Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Mycoses; Structure- | 2011 |
Novel (E)-1-(4-methyl-2-(alkylamino)thiazol-5-yl)-3-arylprop-2-en-1-ones as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; M | 2011 |
Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
Topics: Animals; Anti-Infective Agents; Artemia; Bacteria; Bacterial Infections; Blood Glucose; Diabetes Mel | 2012 |
Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies.
Topics: A549 Cells; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Fungi; HEK | 2016 |
Formulation and Development of Hyaluronic Acid based Gel with Ketoconazole-Loaded Nanostructured Lipid Carriers in Fungal Infection.
Topics: Antifungal Agents; Drug Carriers; Humans; Hyaluronic Acid; Ketoconazole; Lipids; Mycoses | 2023 |
Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: Comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Candida albicans; Colloid | 2020 |
Silver nanoparticles from Pilimelia columellifera subsp. pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses.
Topics: 3T3 Cells; Actinobacteria; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candid | 2017 |
Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Drug Evaluation, Preclinical; Drug Interactions; | 2019 |
Severe retention hyperkeratosis occurring with Susac syndrome.
Topics: Administration, Cutaneous; Bacterial Infections; Chlorhexidine; Facial Dermatoses; Female; Humans; K | 2010 |
[Management of invasive fungal infections in children].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Echinocandins; Humans; Ketoconazole; Mycoses; | 2011 |
Corneal ulcer caused by the new fungal species Sarcopodium oculorum.
Topics: Antifungal Agents; Child; Corneal Ulcer; Eye Infections, Fungal; Humans; Keratitis; Ketoconazole; Ma | 2002 |
Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole.
Topics: Agastache; Allylbenzene Derivatives; Anisoles; Antifungal Agents; Drug Interactions; Drug Synergism; | 2003 |
[Conjunctival infection due to penicillium SP].
Topics: Aged; Amphotericin B; Antifungal Agents; Conjunctivitis; Eye Infections, Fungal; Humans; Ketoconazol | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acremonium; Aged; Antifungal Agents; Aspergillus; Candida; Child; Drug Resistance, Fungal; Female; F | 2003 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans | 2004 |
Etest for assessing the susceptibility of filamentous fungi.
Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitiv | 2004 |
Role of ketoconazole in renal transplant recipients.
Topics: Antifungal Agents; Humans; Ketoconazole; Kidney Transplantation; Mycoses; Postoperative Complication | 2005 |
[Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Antineoplastic Agents; Fluconazole; Hema | 2004 |
Fusarium solani breast abscess.
Topics: Abscess; Antifungal Agents; Breast Diseases; Female; Fusarium; Humans; Ketoconazole; Middle Aged; My | 2005 |
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality T | 2005 |
[Penicilliosis in Laos].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Female; HIV Infections; Humans; Ketoconazo | 2006 |
In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.
Topics: Animals; Antifungal Agents; Chelating Agents; Drug Synergism; Horse Diseases; Horses; Itraconazole; | 2006 |
Aureobasidium pullulans keratitis.
Topics: Ascomycota; Corneal Ulcer; Eye Infections, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoco | 2006 |
Otomycosis: clinical features and treatment implications.
Topics: Acetates; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ch | 2006 |
In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Eye Diseases; Fluc | 2006 |
Lecythophora hoffmannii isolated from a case of canine osteomyelitis in Japan.
Topics: Animals; Antifungal Agents; Ascomycota; Biopsy; DNA, Fungal; DNA, Ribosomal; Dog Diseases; Dogs; Dru | 2007 |
Unexpected emergence of acute hepatic injury in patients treated repeatedly with ketoconazole.
Topics: Antifungal Agents; Emergencies; Female; Humans; Ketoconazole; Liver Failure, Acute; Mycoses; Prognos | 2008 |
Phaeohyphomycosis caused by Ulocladium species in a cat.
Topics: Animals; Antifungal Agents; Ascomycota; Cat Diseases; Cats; Dermatomycoses; Female; Itraconazole; Ke | 2008 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Amphotericin B; Humans; Ketoconazole; Leukemia; Mycoses | 1984 |
In vitro susceptibility studies with oxiconazole (Ro 13-8996).
Topics: Antifungal Agents; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mycoses | 1984 |
Drug therapy of systemic fungal infections, Part I.
Topics: Amphotericin B; Biological Availability; Humans; Ketoconazole; Kinetics; Mycoses | 1984 |
[Ketoconazole (Nizoral)--potent oral antimycotic drug. What should one know about its side effects?].
Topics: Humans; Hydrocortisone; Ketoconazole; Liver; Liver Function Tests; Mycoses; Testosterone | 1984 |
Systemic candidiasis in cancer patients.
Topics: Acute Disease; Amphotericin B; Bacterial Infections; Bacteriological Techniques; Candida; Candidiasi | 1984 |
Contraindication of ketoconazole in pregnancy.
Topics: Female; Humans; Ketoconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
High-dose ketoconazole therapy and adrenal and testicular function in humans.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Erectile Dysfunction; Gynecomastia; Humans; Hydr | 1984 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1984 |
Phialophora parasitica, an emerging pathogen.
Topics: Amphotericin B; Chloramphenicol; Cycloheximide; Fluorouracil; Humans; Ketoconazole; Miconazole; Micr | 1984 |
Effective systemic antifungal agents.
Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucyto | 1984 |
Effect of ketoconazole on the in-vitro lymphocyte transformation response to mitogen stimulation.
Topics: Humans; Ketoconazole; Lymphocyte Activation; Mycoses | 1984 |
[Comparative study of an orally and a locally administered antifungal agent in vaginal mycoses].
Topics: Administration, Oral; Adult; Candida; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Micon | 1984 |
Subcutaneous phaeohyphomycosis caused by Exophiala spinifera.
Topics: Flucytosine; Humans; Ketoconazole; Middle Aged; Mitosporic Fungi; Mycoses; Skin; Species Specificity | 1984 |
Ketoconazole.
Topics: Drug Evaluation; Humans; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1982 |
Ketoconazole and fungal CAPD peritonitis.
Topics: Antifungal Agents; Humans; Imidazoles; Ketoconazole; Mycoses; Peritoneal Dialysis; Peritoneal Dialys | 1983 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Acute Disease; Amphotericin B; Humans; Ketoconazole; Leukemia; Mycoses | 1984 |
[Ketoconazole a new broad spectrum antimycotic].
Topics: Adolescent; Adult; Aged; Candida; Candidiasis; Child; Female; Humans; Imidazoles; Ketoconazole; Mala | 1980 |
Miconazole therapy for keratomycosis.
Topics: Adult; Aged; Aspergillosis; Candidiasis; Corneal Diseases; Female; Humans; Imidazoles; Keratitis; Ke | 1981 |
Ketoconazole (Nizoral). A new antifungal agent.
Topics: Antifungal Agents; Humans; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1981 |
Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid.
Topics: Amphotericin B; Antifungal Agents; Biological Assay; Candida; Coccidioides; Humans; Imidazoles; Keto | 1981 |
Ketoconazole approved for systemic fungal infections.
Topics: Antifungal Agents; Humans; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1981 |
[Chronic mycoses can be treated].
Topics: Administration, Oral; Humans; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1982 |
[Research in the treatment of fungal infections].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Humans; Imidazoles; Ketoconazo | 1982 |
Drugs for treatments of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycose | 1982 |
Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens.
Topics: Adolescent; Adult; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Adm | 1982 |
The outlook for antifungal prophylaxis in the compromised host.
Topics: Candidiasis; Humans; Imidazoles; Immunity; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin; P | 1982 |
The successful treatment of mycotic infections in immunosuppressed renal transplant recipients with ketoconazole.
Topics: Adult; Antifungal Agents; Female; Humans; Imidazoles; Immunosuppression Therapy; Ketoconazole; Kidne | 1982 |
Fungal arthritis simulating juvenile rheumatoid arthritis.
Topics: Antifungal Agents; Arthritis, Infectious; Arthritis, Juvenile; Ascomycota; Child; Diagnosis, Differe | 1982 |
[Experiences with the oral antimycotic ketoconazole in vaginal fungal involvement].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Human | 1982 |
In vitro susceptibility of Basidiobolus haptosporus and other zygomycetes to ketoconazole.
Topics: Entomophthora; Fungi; Imidazoles; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Piperazines | 1982 |
Ketoconazole in systemic mycoses.
Topics: Antifungal Agents; Humans; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1983 |
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Child; Child, Preschool; Drug Evaluation; Huma | 1983 |
Oral antifungal therapy. Current status of ketoconazole.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Coccidioidomycosis; Histoplasmosis; Humans; Im | 1983 |
Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dermatomycose | 1983 |
Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Topics: Adolescent; Adult; Antifungal Agents; Arthritis, Infectious; Blastomycosis; Candidiasis; Candidiasis | 1983 |
Treatment of mycoses in cancer patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Drug Therapy, Comb | 1983 |
The antifungal activity of ketoconazole.
Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, | 1983 |
[New case of rhinoentomophtoromycosis. Cure by ketoconazole].
Topics: Adult; Antifungal Agents; Elephantiasis; Entomophthora; Humans; Imidazoles; Ketoconazole; Male; Myco | 1982 |
Ketoconazole therapy for fungal urinary tract infections.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Female; Humans; Imidazoles; Ketoconazole; Male; Myco | 1983 |
[First human case of Drechslera longirostrata mycosis. Spondylodiscitis complicating prosthesis endocarditis. Treatment with combined ketoconazole and amphotericin B].
Topics: Adult; Amphotericin B; Antifungal Agents; Endocarditis; Female; Heart Valve Prosthesis; Humans; Imid | 1982 |
Oral ketoconazole therapy for keratomycosis.
Topics: Administration, Oral; Adult; Corneal Ulcer; Female; Humans; Imidazoles; Keratitis; Ketoconazole; Mal | 1983 |
Management of fungal diseases.
Topics: Blastomycosis; Coccidioidomycosis; Complement Fixation Tests; Histoplasmosis; Humans; Imidazoles; Ke | 1983 |
Antimicrobial treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycose | 1983 |
Therapy of fungal infections.
Topics: Amphotericin B; Animals; Clotrimazole; Dogs; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; | 1982 |
Ketoconazole - a new antifungal agent.
Topics: Antifungal Agents; Humans; Imidazoles; Ketoconazole; Mycoses; Nail Diseases; Piperazines | 1983 |
Treatment of fungal infections in the bones and joints with ketoconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Bone Diseases; Child; Coccidioidomycosis; Humans; Imidazole | 1983 |
Pseudallescheria boydii infection after bone marrow transplantation.
Topics: Adult; Antifungal Agents; Ascomycota; Aspergillosis; Bone Marrow Transplantation; Diagnosis, Differe | 1983 |
[Fungal osteoarthritis of the knee with joint destruction treated with ketoconazole].
Topics: Antifungal Agents; Arthritis, Infectious; Arthrodesis; Child; Humans; Imidazoles; Ketoconazole; Knee | 1983 |
[1 1/2 years' experience with ketoconazol - report of results].
Topics: Antifungal Agents; Candidiasis; Dermatomycoses; Female; Humans; Imidazoles; Ketoconazole; Male; Myco | 1983 |
Treatment of systemic mycoses in dogs.
Topics: Amphotericin B; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Imidazole | 1983 |
Ketoconazole.
Topics: Humans; Ketoconazole; Mycoses | 1983 |
[Ketoconazole in the treatment of onychomycosis].
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Humans; Ketoconazole; Male; Middle | 1983 |
[Side effects of ketoconazole].
Topics: Aged; Dose-Response Relationship, Drug; Endocrine Glands; Female; Humans; Ketoconazole; Liver; Male; | 1983 |
Keratomycosis caused by Acremonium Recifei, treated with keratoplasty, Miconazole and Ketoconazole.
Topics: Acremonium; Administration, Topical; Anti-Bacterial Agents; Corneal Transplantation; Corneal Ulcer; | 1983 |
Antemortem diagnosis of paecilomycosis in a cat.
Topics: Animals; Cat Diseases; Cats; Female; Granuloma; Histoplasmosis; Ketoconazole; Mitosporic Fungi; Myco | 1984 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Mic | 1984 |
Ketoconazole: an alternative.
Topics: Humans; Ketoconazole; Mycoses | 1984 |
Petriellidium boydii pachymeningitis treated with miconazole and ketoconazole.
Topics: Drug Therapy, Combination; Dura Mater; Female; Humans; Ketoconazole; Meningitis; Miconazole; Middle | 1984 |
Treatment of superficial and deep-seated mycoses with oral ketoconazole.
Topics: Administration, Oral; Adult; Aged; Dermatomycoses; Female; Humans; Ketoconazole; Male; Middle Aged; | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergill | 1984 |
Systemic infection by Rhodotorula spp. in the immunocompromised host.
Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liv | 1984 |
[Treatment of complicated urinary tract infections caused by fungi].
Topics: Administration, Oral; Aged; Drug Evaluation; Female; Humans; Ketoconazole; Male; Middle Aged; Mycose | 1984 |
Disposition of maternal ketoconazole in breast milk.
Topics: Adult; Breast Feeding; Female; Humans; Infant; Ketoconazole; Milk, Human; Mycoses; Time Factors | 1995 |
Disseminated opportunistic fungal disease in dogs: 10 cases (1982-1990).
Topics: Animals; Discitis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fungi; Itraconazole; Ketoc | 1995 |
Recent advances in cardiac transplantation.
Topics: Coronary Disease; Cost Savings; Heart Transplantation; Humans; Ketoconazole; Mycoses; Pravastatin | 1995 |
Antifungal effects of Allium sativum (garlic) extract against the Aspergillus species involved in otomycosis.
Topics: Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Clotrimazole; Garlic; Ketoconazole; | 1995 |
Basidiobolomycosis in Ghanaian children.
Topics: Basidiomycota; Child; Child, Preschool; Female; Ghana; Humans; Ketoconazole; Male; Mycoses | 1994 |
Onychomycosis due to Pityrosporum.
Topics: Adult; Aged; Chloroform; Female; Hand Dermatoses; Humans; Ketoconazole; Malassezia; Male; Miconazole | 1993 |
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Utilization; Hospital | 1994 |
Oral azole drugs as systemic antifungal therapy.
Topics: Child; Humans; Ketoconazole; Mycoses | 1994 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1994 |
Itraconazole.
Topics: Antifungal Agents; Blastomycosis; Drug Interactions; Histoplasmosis; Humans; Itraconazole; Ketoconaz | 1993 |
Antimycotic susceptibility testing of agents of black grain eumycetoma.
Topics: Antifungal Agents; Econazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensi | 1993 |
[Strategy for examination and therapy of mycotic keratitis].
Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Dru | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritone | 1993 |
Leg granuloma due to Neocosmospora vasinfecta in a renal graft recipient.
Topics: Granuloma; Humans; Hypocreales; Ketoconazole; Kidney Transplantation; Leg; Male; Middle Aged; Mycose | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1996 |
Azole drug resistance in yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Micr | 1995 |
Trichoderma harzianum peritonitis in peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Bacterial Infections; Diabetes Mellitus, Type 2; Diabeti | 1996 |
Intense photophobia caused by Arthrographis kalrae in a contact lens-wearing patient.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Contact Lenses; Cornea; Eye Infections, Fun | 1997 |
Acremonium infection of the esophagus.
Topics: Acremonium; Barrett Esophagus; Child, Preschool; Cimetidine; Connective Tissue Diseases; Esophageal | 1997 |
Entomophthora coronata infection of the paranasal sinuses: report of a case.
Topics: Administration, Oral; Adult; Antifungal Agents; Chronic Disease; Entomophthora; Ethmoid Sinusitis; F | 1997 |
Nigrospora causing corneal ulcer--a case report.
Topics: Antifungal Agents; Atropine; Cornea; Corneal Diseases; Gentamicins; Humans; Ketoconazole; Male; Mico | 1997 |
In vitro susceptibility of filamentous fungi to itraconazole.
Topics: Antifungal Agents; Aspergillus; Cladosporium; Drug Resistance, Microbial; Fungi; Humans; In Vitro Te | 1995 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Pres | 1999 |
Disseminated mycoses in a dog by Paecilomyces sp.
Topics: Animals; Anorexia; Antifungal Agents; Aorta, Abdominal; Depression; Dog Diseases; Dogs; Fatal Outcom | 2000 |
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot T | 1999 |
Oral penicilliosis in a patient with human immunodeficiency virus in northern Thailand.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Female; HIV Infections; Humans; Ketoconazole; Mouth Dis | 2000 |
Temporary remission of disseminated paecilomycosis in a German shepherd dog treated with ketoconazole.
Topics: Animals; Antifungal Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Ketoconazole; Lameness, Anima | 2001 |
Uptake of Malassezia furfur by human dermal fibroblasts: effect of ketoconazole and cytoskeleton inhibitors.
Topics: Antifungal Agents; Cells, Cultured; Colchicine; Cytochalasin D; Cytoskeleton; Fibroblasts; Humans; K | 2001 |
No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes.
Topics: Amphotericin B; Animals; Antifungal Agents; Antioxidants; Antiprotozoal Agents; Ascorbic Acid; Catal | 2001 |
Mycetoma caused by Fusarium solani with osteolytic lesions on the hand: case report.
Topics: Aged; Antifungal Agents; Fusarium; Hand; Hand Dermatoses; Humans; Ketoconazole; Male; Metacarpus; My | 2002 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1992 |
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Topics: Adult; Aged; Antifungal Agents; Azoles; Carbamazepine; Coccidioides; Cryptococcus neoformans; Drug I | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
An efficacy study of itraconazole in the treatment of Penicillium marneffei infection.
Topics: Adolescent; Adult; Antifungal Agents; Female; HIV Seropositivity; Humans; Itraconazole; Ketoconazole | 1992 |
Phaeohyphomycosis caused by Bipolaris spicifera: an informative case.
Topics: Adult; Brain Abscess; Female; Humans; Ketoconazole; Maxillary Sinusitis; Mitosporic Fungi; Mycoses; | 1992 |
Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Eosinophilia; Folliculitis; Humans; Ketoconazole; Malasse | 1992 |
Nasal and retrobulbar mass in a cat caused by Pythium insidiosum.
Topics: Animals; Antibodies, Fungal; Antifungal Agents; Cat Diseases; Cats; Fluorescent Antibody Technique; | 1991 |
High-dose itraconazole in the treatment of severe mycoses.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Antifungal | 1991 |
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Humans; Itraconazole; Ketoconaz | 1991 |
[In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
Topics: Antifungal Agents; Candida albicans; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
[The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Female | 1991 |
Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle | 1991 |
[Tropical mycoses].
Topics: Antifungal Agents; Blastomycosis; Chromoblastomycosis; Clinical Trials as Topic; Female; Histoplasmo | 1991 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; H | 1991 |
[Itraconazole in systemic fungal infections].
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
[In-vitro and in-vivo activity of itraconazole].
Topics: Animals; Antifungal Agents; Drug Synergism; Drug Therapy, Combination; Fungi; Guinea Pigs; Itraconaz | 1991 |
Rhinofacial zygomycosis caused by Conidiobolus coronatus. A case report.
Topics: Aged; Agricultural Workers' Diseases; Brazil; Edema; Face; Female; Fluconazole; Fungi; Humans; Ketoc | 1991 |
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Dr | 1990 |
Discovering antimycotic drugs: today and tomorrow.
Topics: Antifungal Agents; Azoles; Candidiasis; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; | 1990 |
Clinical use of itraconazole in fungal infections.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1990 |
Itraconazole treatment of phaeohyphomycosis.
Topics: Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Human | 1990 |
European experience with itraconazole in systemic mycoses.
Topics: Antifungal Agents; Aspergillosis; Child; Cryptococcosis; Drug Administration Schedule; Humans; Itrac | 1990 |
The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole.
Topics: Administration, Oral; Antifungal Agents; Drug Resistance, Microbial; Fungi; Itraconazole; Ketoconazo | 1990 |
Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole.
Topics: Administration, Oral; Antifungal Agents; Arthritis, Infectious; Child; Humans; Itraconazole; Ketocon | 1990 |
Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Male; | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole | 1990 |
Chronic, recurrent osteomyelitis caused by Scedosporium inflatum.
Topics: Child; Chronic Disease; Debridement; Drainage; Foot Diseases; Humans; Ketoconazole; Male; Mitosporic | 1990 |
[Trichosporon capitatum septicemia in immunosuppressed patients].
Topics: Adult; Female; Fluconazole; Humans; Immune Tolerance; Ketoconazole; Leukemia, Myeloid, Acute; Male; | 1990 |
[Recent antifungal agents].
Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itra | 1989 |
Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels.
Topics: Adult; Aged; Agranulocytosis; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; M | 1989 |
Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; F | 1989 |
Symposium: Itraconazole and its use in systemic mycoses. Antwerpen, June 22, 1989. Proceedings.
Topics: Animals; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
Incidence, severity, and prevention of infections in chronic granulomatous disease.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Genetic Linkage; Granu | 1989 |
Phaeohyphomycosis caused by Exophiala spinifera in two cats.
Topics: Animals; Cat Diseases; Cats; Dermatomycoses; Exophiala; Female; Ketoconazole; Male; Mycoses; Nose Di | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1987 |
Ocular involvement in mycotic sinusitis caused by Bipolaris.
Topics: Adolescent; Humans; Itraconazole; Ketoconazole; Magnetic Resonance Imaging; Male; Mycoses; Sinusitis | 1988 |
Experience with itraconazole in treatment of fungal infections.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Drug Evaluation; Female; Humans; Itrac | 1987 |
[Itraconazole in the treatment of deep mycoses].
Topics: Antifungal Agents; Aspergillosis; Drug Evaluation; Humans; Itraconazole; Ketoconazole; Lung Diseases | 1987 |
Oral itraconazole therapy for mycotic keratitis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Child; Female; Fusarium; Humans; Itraconazole; | 1988 |
Treatment of mycoses with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Follow-Up Studies; Humans; Itraconazole; | 1988 |
Itraconazole therapy for fungal keratitis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Administration Routes; Female; Humans; Itraco | 1987 |
Adrenal response to corticotropin during therapy with itraconazole.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Humans; Hydrocortisone; Itraconazole; Ketoconazole; Kin | 1987 |
[Prevention of fungal infections with ketoconazole in cancer patients receiving cytostatic therapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Ketoconazole; Mal | 1988 |
[Histopathologic observations on acute liver lesions in patients taking Nizoralt (ketokonazol)].
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Ketoconazole; Liver; Liver Cirrhosis; | 1988 |
Antifungal susceptibility testing of Trichosporon beigelii to imidazole compounds.
Topics: Amphotericin B; Clotrimazole; Culture Media; Econazole; Genital Diseases, Male; Hair; Humans; Imidaz | 1988 |
Bilateral Pseudallescheria boydii endophthalmitis in an immunocompromised patient.
Topics: Amphotericin B; Ascomycota; Drug Resistance, Microbial; Endophthalmitis; Humans; Immune Tolerance; K | 1988 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Op | 1988 |
Parasitosis and mycosis of the central nervous system: 20 years of experience.
Topics: Central Nervous System Diseases; Child; Child, Preschool; Cysticercosis; Female; Humans; Infant; Ket | 1988 |
[Rhinoentomophthoromycosis. Therapeutic aspects of the 2 first Congolese cases].
Topics: Adult; Congo; Female; Fungi; Humans; Ketoconazole; Male; Middle Aged; Mycoses; Nose Diseases; Surger | 1988 |
Activity of terbinafine in experimental fungal infections of laboratory animals.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dermatomycoses; Female; Guinea | 1987 |
Treatment of vaginal mycosis with Nizoral tablet.
Topics: Administration, Oral; Female; Humans; Ketoconazole; Mycoses; Vaginal Diseases | 1986 |
Treatment of vaginal discharge caused by blastomycetes with nizoral tablet.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Ketoconazole; Leukorrhea | 1986 |
Incidence and treatment of fungal infections in neutropenic patients.
Topics: Agranulocytosis; Amphotericin B; Female; Humans; Ketoconazole; Leukemia, Lymphoid; Leukemia, Myeloid | 1987 |
Successful treatment of Paecilomyces lilacinus endophthalmitis following cataract extraction with intraocular lens implantation.
Topics: Aged; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Female; Hu | 1987 |
[Therapeutic possibilities in mycotic corneal processes].
Topics: Adult; Aged; Drug Therapy, Combination; Humans; Keratitis; Ketoconazole; Male; Middle Aged; Mycoses; | 1987 |
Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents.
Topics: Aspergillus fumigatus; Candida; Candida albicans; Chromatography, High Pressure Liquid; Cryptococcus | 1986 |
Ketoconazole--theophylline interaction.
Topics: Asthma; Drug Interactions; Humans; Ketoconazole; Male; Middle Aged; Mycoses; Theophylline | 1987 |
Entomophthoromycosis due to Basidiobolus in Somalia.
Topics: Child; Entomophthora; Humans; Ketoconazole; Male; Mycoses | 1987 |
Cerebral phaeohyphomycosis.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans; | 1987 |
Subcutaneous phaeohyphomycosis caused by Exserohilum rostratum in an immunocompetent host.
Topics: Abscess; Animals; Bites and Stings; Female; Humans; Ketoconazole; Leg; Middle Aged; Mitosporic Fungi | 1987 |
Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis.
Topics: Adolescent; Adult; Aged; Child, Preschool; Female; Humans; Keratitis; Ketoconazole; Male; Miconazole | 1986 |
Antifungal activity of ketoconazole with emphasis on zoophilic fungal pathogens.
Topics: Animals; In Vitro Techniques; Ketoconazole; Mitosporic Fungi; Mycoses; Yeasts | 1986 |
Treatment of systemic mycoses with ketoconazole: studies of ketoconazole serum levels.
Topics: Blastomycosis; Child, Preschool; Coccidioidomycosis; Cryptococcosis; Histoplasmosis; Humans; Ketocon | 1986 |
Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis.
Topics: Animals; Humans; Keratitis; Ketoconazole; Miconazole; Mycoses; Rabbits | 1986 |
Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Vulvovaginal; Female; Guinea Pi | 1986 |
Treatment of otolaryngological mycoses with Nizoral.
Topics: Adolescent; Adult; Aged; Candidiasis, Oral; Female; Humans; Ketoconazole; Laryngeal Diseases; Male; | 1985 |
Ketoconazole and the antifungals.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Ketocona | 1985 |
Ketoconazole: clinical pharmacology and therapeutic recommendations.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Interactions; Female; Humans; | 1986 |
Ketoconazole: clinical evaluation in severe fungal infections.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; | 1986 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans | 1986 |
[Prevention of mycoses caused by yeasts].
Topics: Candidiasis; Cryptococcosis; Disinfection; Humans; Infant; Infant, Newborn; Infant, Premature, Disea | 1985 |
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; | 1985 |
Topical ketoconazole for fungal keratitis.
Topics: Administration, Topical; Adult; Aspergillosis; Female; Fusarium; Humans; Keratitis; Ketoconazole; Ma | 1985 |
[Ketoconazole in the prevention of mycotic complications during cytostatic treatment of leukemias and lymphomas].
Topics: Female; Humans; Ketoconazole; Leukemia; Lymphoma; Male; Mycoses | 1985 |
Wangiella dermatitidis endocarditis in an intravenous drug user.
Topics: Adult; Amphotericin B; Aortic Valve; Drug Therapy, Combination; Endocarditis; Heart Valve Diseases; | 1985 |
Acremonium kiliense osteomyelitis of the calvarium.
Topics: Adult; Amphotericin B; Clindamycin; Humans; Ketoconazole; Male; Mitosporic Fungi; Mycoses; Osteomyel | 1985 |
Ketoconazole and resistant Blastocystis hominis infection.
Topics: Aged; Diarrhea; Drug Resistance, Microbial; Female; Fungi; Humans; Ketoconazole; Mycoses | 1985 |
[The yellow peril].
Topics: Chemical and Drug Induced Liver Injury; Humans; Ketoconazole; Mycoses | 1985 |
Limits of antifungal prophylaxis by ketoconazole in leukemic patients.
Topics: Adult; Biological Assay; Female; Humans; Ketoconazole; Leukemia; Male; Mycoses | 1985 |
Trichosporon infection in a cat.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Chemical and Drug Induced Liver Injury; Humans; Ketocon | 1985 |
Ketoconazole. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
Topics: Administration, Oral; Child; Drug Tolerance; Humans; Ketoconazole; Mycoses; Tissue Distribution | 1985 |